Jay Matushak - NeueHealth Chief Officer
| NEUE Stock | 5.00 0.07 1.38% |
Executive
Jay Matushak is Chief Officer of NeueHealth
| Age | 49 |
| Address | 9250 NW 36th St, Doral, FL, United States, 33178 |
| Phone | 612 238 1321 |
| Web | https://www.neuehealth.com |
Latest Insider Transactions
Jay Matushak Latest Insider Activity
Tracking and analyzing the buying and selling activities of Jay Matushak against NeueHealth stock is an integral part of due diligence when investing in NeueHealth. Jay Matushak insider activity provides valuable insight into whether NeueHealth is net buyers or sellers over its current business cycle. Note, NeueHealth insiders must abide by specific rules, including filing SEC forms every time they buy or sell NeueHealth'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
Jay Matushak over a month ago Disposition of tradable shares by Jay Matushak of NeueHealth at 5.18 subject to Rule 16b-3 | ||
Jay Matushak over a month ago Disposition of 263 shares by Jay Matushak of NeueHealth subject to Rule 16b-3 | ||
Jay Matushak over three months ago Acquisition by Jay Matushak of 978 shares of NeueHealth subject to Rule 16b-3 | ||
Jay Matushak over six months ago Disposition of 317 shares by Jay Matushak of NeueHealth at 6.05 subject to Rule 16b-3 |
NeueHealth Management Efficiency
The company has return on total asset (ROA) of (0.0358) % which means that it has lost $0.0358 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (1.8326) %, meaning that it created substantial loss on money invested by shareholders. NeueHealth's management efficiency ratios could be used to measure how well NeueHealth manages its routine affairs as well as how well it operates its assets and liabilities. At present, NeueHealth's Return On Equity is projected to increase slightly based on the last few years of reporting. At present, NeueHealth's Intangible Assets are projected to increase significantly based on the last few years of reporting. The current year's Debt To Assets is expected to grow to 0.32, whereas Non Current Assets Total are forecasted to decline to about 129.7 M.Similar Executives
| Showing other executives | EXECUTIVE Age | ||
| Gregory Cameron | CF Industries Holdings | 55 | |
| Andy Hesselbach | WEC Energy Group | N/A | |
| Mary CPA | WEC Energy Group | 59 | |
| David Tuerff | Aris Water Solutions | N/A | |
| David Bilby | CF Industries Holdings | N/A | |
| Rasesh Patel | NRG Energy | 50 | |
| Drew Dixon | Aris Water Solutions | N/A | |
| Jon Ricker | Aris Water Solutions | N/A | |
| Lindsay Ellis | Kinetik Holdings | N/A | |
| John Zaganczyk | WEC Energy Group | N/A | |
| Christopher Moser | NRG Energy | 53 | |
| Kristen Gajewski | Avient Corp | 42 | |
| Leslie Sequeira | Avient Corp | N/A | |
| John Midea | Avient Corp | 60 | |
| Dylan Brunt | Aris Water Solutions | 39 | |
| Gerald Spencer | NRG Energy | 42 | |
| JD Hunt | Aris Water Solutions | 43 | |
| Martin CFA | CF Industries Holdings | N/A | |
| Gin Kinney | NRG Energy | N/A | |
| Kurt Schuering | Avient Corp | 60 | |
| Judith Lagano | NRG Energy | 58 | |
Management Performance
| Return On Equity | -1.83 | ||||
| Return On Asset | -0.0358 |
NeueHealth Leadership Team
Elected by the shareholders, the NeueHealth's board of directors comprises two types of representatives: NeueHealth inside directors who are chosen from within the company, and outside directors, selected externally and held independent of NeueHealth. The board's role is to monitor NeueHealth's management team and ensure that shareholders' interests are well served. NeueHealth's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, NeueHealth's outside directors are responsible for providing unbiased perspectives on the board's policies.
| George III, CEO Chairman | ||
| Megan North, President NeueSolutions | ||
| Jeff Craig, General Secretary | ||
| Jeffrey Scherman, Chief Officer | ||
| Jay Matushak, Chief Officer | ||
| Joaquin MD, President Care | ||
| Tomas Orozco, Executive Care | ||
| Robert Sheehy, CoFounder Chairman | ||
| Stacy Conti, Chief Officer | ||
| Jeff JD, General Secretary |
NeueHealth Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is NeueHealth a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -1.83 | ||||
| Return On Asset | -0.0358 | ||||
| Profit Margin | (0.99) % | ||||
| Operating Margin | (0.16) % | ||||
| Current Valuation | 1.37 B | ||||
| Shares Outstanding | 8.22 M | ||||
| Shares Owned By Insiders | 5.48 % | ||||
| Shares Owned By Institutions | 63.60 % | ||||
| Number Of Shares Shorted | 42.2 K | ||||
| Revenue | 1.16 B |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether NeueHealth is a strong investment it is important to analyze NeueHealth's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact NeueHealth's future performance. For an informed investment choice regarding NeueHealth Stock, refer to the following important reports:Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in NeueHealth. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in employment. For information on how to trade NeueHealth Stock refer to our How to Trade NeueHealth Stock guide.You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of NeueHealth. If investors know NeueHealth will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about NeueHealth listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Revenue Per Share 145.939 | Quarterly Revenue Growth 0.286 | Return On Assets (0.04) | Return On Equity (1.83) |
The market value of NeueHealth is measured differently than its book value, which is the value of NeueHealth that is recorded on the company's balance sheet. Investors also form their own opinion of NeueHealth's value that differs from its market value or its book value, called intrinsic value, which is NeueHealth's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because NeueHealth's market value can be influenced by many factors that don't directly affect NeueHealth's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between NeueHealth's value and its price as these two are different measures arrived at by different means. Investors typically determine if NeueHealth is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, NeueHealth's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.